CPD Courses

Turning numbers into action: optimising care in T2DM and CKD

Seminar • AstraZeneca

About the CPD course

Developed to support HCPs in primary care to better understand and apply the learnings from clinical trials reporting into their day-to-day practice. Spanning trial design; inclusion criteria; endpoints; reporting of absolute risk reduction; relative risk reduction; Numbers Need to Treat; and much more; this presentation contextualises clinical trial information through the lens of a key trial in chronic kidney disease relevant to primary care physicians’ practice.

CPD Provider

AstraZeneca

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.

More CPD courses by AstraZeneca

Healthcare & Medical

Cardiorenal protection: a risk-based approach to m...

AstraZeneca

An interactive and engaging presentation developed for UK based GPs; practice based and primary care...
Literature
Healthcare & Medical

Simplifying the management of heart failure across...

AstraZeneca

A thorough presentation developed for UK based cardiologists and cardiology-specialist nurses; highl...
Seminar
Healthcare & Medical

Are you confident taking a risk-based approach in...

AstraZeneca

An update to the NICE type 2 diabetes guidelines (NG28) has seen a paradigm shift in how type 2 diab...
Online Course
Healthcare & Medical

Are you considering cardiovascular risk in type 2...

AstraZeneca

The treatment of type 2 diabetes (T2D) has evolved from blood glucose control being recognised as th...
Training Video

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy